Abstract:Background High blood pressure is a prognostic factor for acute stroke, but blood pressure variability might also independently predict outcome. We assessed the prognostic value of blood pressure variability in participants of INTERACT2, an open-label randomised controlled trial (ClinicalTrials.gov number NCT00716079).Methods INTERACT2 enrolled 2839 adults with spontaneous intracerebral haemorrhage (ICH) and high systolic blood pressure (150-220 mm Hg) without a definite indication or contraindication to early intensive treatment to reduce blood pressure. Participants were randomly assigned to intensive treatment (target systolic blood pressure <140 mm Hg within 1 h using locally available intravenous drugs) or guideline-recommended treatment (target systolic blood pressure <180 mm Hg) within 6 h of onset of ICH. The primary outcome was death or major disability at 90 days (modified Rankin Scale score >= 3) and the secondary outcome was an ordinal shift in modified Rankin Scale scores at 90 days, assessed by investigators masked to treatment allocation. Blood pressure variability was defined according to standard criteria: five measurements were taken in the first 24 h (hyperacute phase) and 12 over days 2-7 (acute phase). We estimated associations between blood pressure variability and outcomes with logistic and proportional odds regression models. The key parameter for blood pressure variability was standard deviation (SD) of systolic blood pressure, categorised into quintiles.Findings We studied 2645 (93.2%) participants in the hyperacute phase and 2347 (82.7%) in the acute phase. In both treatment cohorts combined, SD of systolic blood pressure had a significant linear association with the primary outcome for both the hyperacute phase (highest quintile adjusted OR 1.41, 95% CI 1.05-1.90; p(trend)=0.0167) and the acute phase (highest quintile adjusted OR 1.57, 95% CI 1.14-2.17; p(trend)=0.0124). The strongest predictors of outcome were maximum systolic blood pressure in the hyperacute phase and SD of systolic blood pressure in the acute phase. Associations were similar for the secondary outcome (for the hyperacute phase, highest quintile adjusted OR 1.43, 95% CI 1.14-1.80; p(trend)=0.0014; for the acute phase OR 1.46, 95% CI 1.13-1.88; p(trend)=0.0044).Interpretation Systolic blood pressure variability seems to predict a poor outcome in patients with acute intracerebral haemorrhage. The benefits of early treatment to reduce systolic blood pressure to 140 mm Hg might be enhanced by smooth and sustained control, and particularly by avoiding peaks in systolic blood pressure.Funding National Health and Medical Research Council of Australia.

Intracerebral hemorrhage location and outcome among INTERACT2 participants

Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies.

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2

Significance of Intraventricular Hemorrhage in Acute Intracerebral Hemorrhage

Early Cognitive Impairment after Intracerebral Hemorrhage in the INTERACT1 Study.

Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage

OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE.

Significance of Hematoma Shape and Density in Intracerebral Hemorrhage

Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.

Blood Pressure Variability and Outcome after Acute Intracerebral Haemorrhage : a Post-Hoc Analysis of INTERACT 2 , a Randomised Controlled Trial *

Prognostic Significance of Delayed Intraventricular Haemorrhage in the Interact Studies

Measures of intracranial compartments in acute intracerebral haemorrhage: data from the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke-2 Trial (RIGHT-2)

Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies.

Predictive Accuracy of Clinicians Estimates of Death and Recovery after Acute Intracerebral Hemorrhage: Pre-Specified Analysis in INTERACT3 Study

Hematoma Growth and Outcomes in Intracerebral Hemorrhage: the INTERACT1 Study.

Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage

Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study.

Poor Utility Of Grading Scales In Acute Intracerebral Hemorrhage: Results From The Interact2 Trial

Older Age is a Strong Predictor for Poor Outcome in Intracerebral Haemorrhage: the INTERACT2 Study.

Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies